Clinical trial
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate…
NCT00002889 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00002889 |
|---|---|
| Title | Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer |
| Official title | PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | flutamide, goserelin, leuprolide acetate, low-LET photon therapy |
| Enrollment | 180 |
| Start date | May 1, 1997 |
| Primary completion | Jan 1, 2004 |
| Completion | Jun 1, 2009 |
| First posted | Apr 22, 2004 |
| Last update posted | Aug 18, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: